Xencor, Inc.
XNCR •
Buy Open
Signal type
Buy
Status
Open
Open Price
$12.83
Stop Loss
$11.11
Performance
-2.46%
Days Open
13
Signal Setup
Signal Type Buy
Status Open
Open Date Apr 2, 2026
Open Price $12.83
Stop Loss $11.11
Timespan Day
Company Profile
Name Xencor, Inc.
Ticker XNCR
Market Cap $559.40M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $12.51
List Date Dec 3, 2013
Description
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
Website Open Company Website